Pain Management and the Role of the Laboratory

Lynne A Brunelle, Ph.D.

~Objectives:
-Review the current state of illicit drug use both nationally and regionally, the role of the laboratory in drug testing and the methodology involved, the trends of newer illicit drugs and the future state of testing for these.

Lynn A. Brunelle, PhD, is an Assistant Director of Clinical Chemistry Services at Dartmouth-Hitchcock Medical Center in Lebanon, NH, the Director of the Southern Region Laboratories for the Dartmouth Health Clinics, and an Assistant Professor at the Geisel School of Medicine, Dartmouth College. Prior to 2022, she was the Senior Director of Laboratory and Testing Operations for the Accelerator Laboratory at Quanterix in Billerica, MA, and the VP of Operations for ALPCO, an immunoassay products company in Salem, NH. Lynn has an undergraduate degree in Biochemistry and Molecular Biology from McMaster University, a PhD in Biomedical Sciences specializing in bleeding disorders from the University of Guelph, and is board certified by the American Association of Clinical Chemistry.

Dr. Brunelle has no relevant financial relationships to disclose.

The Maine Medical Education Trust designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This includes 1 credit that is compliant with New Hampshire RSA 318-B:40 - opioid education requirement.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Maine Medical Education Trust and NHMS.  The Maine Medical Education Trust is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.